• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4836061)   Today's Articles (1839)
For: Li Y, Yang ZQ, Ye H, Qi L, Hu JW. Application of 18F-FDG PET/CT imaging in diagnosing bladder tumor metastasis lesions. ACTA ACUST UNITED AC 2013;33:234-237. [DOI: 10.1007/s11596-013-1103-1] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2012] [Indexed: 10/26/2022]
Number Cited by Other Article(s)
1
Hinsenveld FJ, Noordman BJ, Boormans JL, Voortman J, van Leenders GJLH, van der Pas SL, van Beek SC, Oprea-Lager DE, Vis AN. Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial. BMC Cancer 2021;21:1161. [PMID: 34715822 PMCID: PMC8556888 DOI: 10.1186/s12885-021-08840-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2021] [Accepted: 10/05/2021] [Indexed: 11/21/2022]  Open
2
18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in muscle-invasive bladder cancer. Curr Opin Urol 2020;30:654-664. [PMID: 32701719 DOI: 10.1097/mou.0000000000000798] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
3
Fonteyne V, De Man K, Decaestecker K, De Visschere P, Dirix P, De Meerleer G, Berghen C, Ost P, Villeirs G. PET–CT for staging patients with muscle invasive bladder cancer: is it more than just a fancy tool? Clin Transl Imaging 2020. [DOI: 10.1007/s40336-020-00397-7] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
4
The role of PET/CT in the evaluation of patients with urothelial cancer: a systematic review and meta-analysis. Clin Transl Imaging 2018. [DOI: 10.1007/s40336-018-0269-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
5
Kitajima K, Yamamoto S, Fukushima K, Yamakado K, Katsuura T, Igarashi Y, Kawanaka Y, Mouri M, Hirota S. FDG-PET/CT as a post-treatment restaging tool in urothelial carcinoma: Comparison with contrast-enhanced CT. Eur J Radiol 2016;85:593-8. [DOI: 10.1016/j.ejrad.2015.12.017] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2015] [Revised: 12/17/2015] [Accepted: 12/21/2015] [Indexed: 11/25/2022]
6
Parotid metastasis from carcinoma urinary bladder treated with CyberKnife-based stereotactic body radiotherapy: case report and review of literature. JOURNAL OF RADIOTHERAPY IN PRACTICE 2014. [DOI: 10.1017/s1460396914000387] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA